Busan Jinhae Free Economic Zone Authority to host global advanced bio symposium, spotlighting drug development and alternative testing methods

[Financial News] The Busan Jinhae Free Economic Zone Authority is exploring directions for the development of advanced biotechnology and its potential for industrialization with global bio experts.
The Busan Jinhae Free Economic Zone Authority said on the 9th that it will host the 2026 Global Advanced Bio Symposium jointly with Prestige BioPharma IDC on the afternoon of the 16th at the company’s ROA Hall.
The event, themed “Global Advanced Bio Innovation and Industrialization: The Future of Next-Generation Drug Development and Alternative Testing Methods,” will share research trends in advanced technologies such as artificial intelligence (AI), organ-on-a-chip technology and microphysiological systems, as well as their potential applications in drug development, and discuss ways to commercialize them.
The symposium will feature a keynote address, presentations, an expert panel discussion and networking, in that order.
The keynote address will be delivered by Dan Huh, an endowed professor in the Department of Bioengineering at the University of Pennsylvania in the United States, on the topic “Organ-on-a-Chip and Microphysiological Systems: From Replacing Animal Testing to the Future of Drug Development.” Huh, a world-renowned organ-on-a-chip researcher, will discuss advances in technologies that mimic human physiological environments and their potential applications in drug development.
Kim Yong-tae, CEO of Mepsgen, will speak on innovation and commercialization in organ-on-a-chip technology; Professor Kim Jeong-hyeon of Ajou University will cover global trends in advanced alternative testing methods; and Group Head Pyo Jeong-hun of Prestige BioPharma IDC will discuss the future of antibody drug development.
The expert panel discussion will include the speakers, as well as Team Leader Lee Gyeong-ryun of the Korea Research Institute of Bioscience and Biotechnology, Professor Heo Jin of Pusan National University College of Medicine, and Director Kim Dae-gyeong of Highcelltech. They will discuss the development of advanced biotechnology and the challenges of commercializing it.
Busan Jinhae Free Economic Zone Authority Commissioner Park Seong-ho said, “Through this event, we will strengthen cooperative networks between regional biotech companies and innovation institutions and identify opportunities for collaboration that will help attract advanced bio industries to the southeastern region and promote technological innovation and industrialization.”

[email protected] Kwon Byung-seok Reporter